Skip to Content

Arformoterol Side Effects

For the Consumer

Applies to arformoterol: inhalation solution

Along with its needed effects, arformoterol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking arformoterol:

More Common

Less Common

  • Bloating or swelling of the face, arms, hands, lower legs, or feet
  • chills
  • cough
  • difficult or labored breathing
  • fever
  • general feeling of discomfort or illness
  • headache
  • joint pain
  • leg cramps
  • loss of appetite
  • muscle aches and pains
  • nausea
  • pain or tenderness around the eyes and cheekbones
  • rapid weight gain
  • rash
  • shivering
  • shortness of breath
  • sore throat
  • stuffy or runny nose
  • sweating
  • tightness of the chest
  • tingling of the hands or feet
  • trouble with sleeping
  • troubled breathing
  • unusual tiredness or weakness
  • unusual weight gain or loss
  • vomiting
  • wheezing

Get emergency help immediately if any of the following symptoms of overdose occur while taking arformoterol:

Symptoms of Overdose

  • Arm, back, or jaw pain
  • blurred vision
  • chest discomfort
  • chest tightness or heaviness
  • confusion
  • convulsions
  • decreased urine
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • drowsiness
  • dry mouth
  • fast, pounding, or irregular heartbeat or pulse
  • increased thirst
  • mood changes
  • muscle pain or cramps
  • muscle tremors
  • nervousness
  • no blood pressure or pulse
  • numbness or tingling in the hands, feet, or lips
  • pounding in the ears
  • rapid, deep breathing
  • restlessness
  • slow heartbeat
  • stomach cramps
  • stopping of the heart
  • tremor
  • unconsciousness

For Healthcare Professionals

Applies to arformoterol: inhalation solution

Respiratory

Two double-blind, placebo-controlled clinical trials showed a decreased or comparable incidence of COPD exacerbations when compared to placebo. COPD exacerbations occurred at a rate of 12.1% for those patients receiving the drug and 15.1% for those patients receiving placebo.[Ref]

Common (1% to 10%): Dyspnea, sinusitis, flu syndrome, pulmonary and chest congestion

Frequency not reported (Less than 2%): Respiratory disorder, voice alteration[Ref]

Cardiovascular

Common (1% to 10%): Chest pain, peripheral edema

Frequency not reported (Less than 2%): Arteriosclerosis, atrial flutter, AV block, congestive heart failure, heart block, myocardial infarct, QT interval prolongation, supraventricular tachycardia, inverted T-wave[Ref]

Two double-blind, placebo-controlled clinical trials showed a decreased or comparable incidence of cardiovascular events. Frequency of all cardiovascular events was 6.9% in those using the drug and 13.3% in the placebo group. No frequently occurring, defined as 1% or greater than placebo, cardiovascular events were associated.[Ref]

Dermatologic

Common (1% to 10%): Rash

Frequency not reported (Less than 2%): Dry skin, herpes simplex, herpes zoster, skin discoloration, skin hypertrophy[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea

Frequency not reported (Less than 2%): Constipation, gastritis, melena, oral moniliasis, periodontal abscess, rectal hemorrhage[Ref]

Musculoskeletal

Common (1% to 10%): Back pain, leg cramps

Frequency not reported (Less than 2%): Neck rigidity, pelvic pain, arthralgia, arthritis, rheumatoid arthritis, bone disorder, tendinous contracture[Ref]

Hematologic

Frequency not reported (Less than 2%): Retroperitoneal hemorrhage

Hypersensitivity

Frequency not reported (Less than 2%): Allergic reaction

Local

Frequency not reported (Less than 2%): Injection site pain

Metabolic

Frequency not reported (Less than 2%): Dehydration, edema, glucose tolerance decreased, gout, hyperglycemia, hyperlipidemia, hypoglycemia, hypokalemia

Nervous system

Frequency not reported (Less than 2%): Agitation, cerebral infarct, circumoral paresthesia, hypokinesia, somnolence, tremor, paralysis

Ocular

Frequency not reported (Less than 2%): Abnormal vision, glaucoma

Oncologic

Frequency not reported (Less than 2%): Neoplasm, carcinoma of the lung, breast neoplasm

Other

Common (1% to 10%): Pain

Frequency not reported (Less than 2%): Digitalis intoxication, abscess, fever, hernia

Genitourinary

Frequency not reported (Less than 2%): Calcium crystalluria, cystitis, glycosuria, hematuria, kidney calculus, nocturia, PSA increase, pyuria, urinary tract disorder, urine abnormality

References

1. "Product Information. Brovana (arformoterol)." Sepracor Inc, Marlborough, MA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide